UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.220

Sortiert nach

Progress in adjuvant systemic therapy for breast cancer

Nature reviews. Clinical oncology, 2019-01, Vol.16 (1), p.27-44

2019

Link zum Volltext

Verfügbarkeit prüfen

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Breast cancer research : BCR, 2019-02, Vol.21 (1), p.28-28, Article 28

2019

Link zum Volltext

Verfügbarkeit prüfen

NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)

BMC cancer, 2020-05, Vol.20 (1), p.485-9, Article 485

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use

Breast cancer research : BCR, 2021-07, Vol.23 (1), p.74-74, Article 74

2021

Link zum Volltext

Verfügbarkeit prüfen

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer

BMC cancer, 2023-05, Vol.23 (1), p.422-422, Article 422

2023

Link zum Volltext

Verfügbarkeit prüfen

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

BMC cancer, 2019-10, Vol.19 (1), p.952-952, Article 952

2019

Link zum Volltext

Verfügbarkeit prüfen

mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial

BMC cancer, 2024-03, Vol.24 (1), p.397-397

2024

Link zum Volltext

Verfügbarkeit prüfen

Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study

BMC cancer, 2024-03, Vol.24 (1), p.344-344

2024

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data

BMC cancer, 2018-12, Vol.18 (1), p.1214-12, Article 1214

2018

Link zum Volltext

Verfügbarkeit prüfen

Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial

Breast cancer research : BCR, 2019-02, Vol.21 (1), p.32-32, Article 32

2019

Link zum Volltext

Verfügbarkeit prüfen

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer

BMC cancer, 2018-06, Vol.18 (1), p.699-699, Article 699

2018

Link zum Volltext

Verfügbarkeit prüfen

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

Molecular cancer, 2023-01, Vol.22 (1), p.13-6, Article 13

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

BMC cancer, 2021-01, Vol.21 (1), p.78-11, Article 78

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database

BMC cancer, 2020-02, Vol.20 (1), p.136-136, Article 136

2020

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

BMC cancer, 2020-11, Vol.20 (1), p.1108-1108, Article 1108

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis

BMC cancer, 2018-01, Vol.18 (1), p.118-10, Article 118

2018

Link zum Volltext

Verfügbarkeit prüfen

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study

BMC cancer, 2024-02, Vol.24 (1), p.164-164, Article 164

2024

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

The pharmacogenomics journal, 2020-02, Vol.20 (1), p.27-46

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study

BMC cancer, 2021-12, Vol.21 (1), p.1301-1301, Article 1301

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis

BMC cancer, 2019-07, Vol.19 (1), p.716-716, Article 716

2019

Link zum Volltext

Verfügbarkeit prüfen

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy

BMC cancer, 2020-06, Vol.20 (1), p.498-10, Article 498

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.220

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.013)
Mit Volltextzugriff
(956)

Publikationsform

Sprache

Englisch
(1.219)
Japanisch
(120)
Französisch
(8)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bmc Cancer
(480)
Breast Cancer Research : Bcr
(153)
Nature Reviews. Clinical Oncology
(86)
Business Wire
(76)
Pr Newswire
(74)
Bone Marrow Transplantation
(43)
Pharmacoeconomics
(36)
Breast Cancer Research
(30)
Journal Of The Pakistan Medical Association
(27)
Drugs & Aging
(20)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer

Progress in adjuvant systemic therapy for breast cancer

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)

Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer

Lymph node ratio as valuable predictor in pancreatic cancer treated with R0 resection and adjuvant treatment

mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial

Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study

Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data

Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

The role of capecitabine-based neoadjuvant and adjuvant chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database

Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis

ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

Effectiveness and safety of pegylated liposomal doxorubicin versus epirubicin as neoadjuvant or adjuvant chemotherapy for breast cancer: a real-world study

Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis

Optimize the dose of oxaliplatin for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy followed by radical surgery and adjuvant chemotherapy

Aktive Filter

Suchergebnisse filtern